TAILIEUCHUNG - Interagency Guideline on Opioid Dosing for Chronic Non-cancer Pain:  An educational aid to improve   care and safety with opioid therapy

Tham khảo sách interagency guideline on opioid dosing for chronic non-cancer pain: an educational aid to improve care and safety with opioid therapy, y tế - sức khoẻ, y học thường thức phục vụ nhu cầu học tập, nghiên cứu và làm việc hiệu quả | AGENCY MEDICAL DIRECTORS GROUP Interagency Guideline on Opioid Dosing for Chronic Non-cancer Pain An educational aid to improve care and safety with opioid therapy 2010 Update What is New in this Revised Guideline New data including scientific evidence to support the 120mg MED dosing threshold Tools for calculating dosages of opioids during treatment and when tapering Validated screening tools for assessing substance abuse mental health and addiction Validated two-item scale for tracking function and pain Urine drug testing guidance and algorithm Information on access to mentoring and consultations including reimbursement options New patient education materials and resources Guidance on coordinating with emergency departments to reduce opioid abuse New clinical tools and resources to help streamline clinical care You can find this guideline and related tools at the Washington State Agency Medical Directors site at Table of Contents 2010 How this guideline is Part I. Guidelines for initiating transitioning and maintaining oral opioids for chronic non-cancer pain . 3 Dosing threshold for pain BEFORE you decide to prescribe opioids for chronic AFTER you decide with the patient to prescribe chronic opioid Principles for safely prescribing chronic opioid therapy. 5 Screening and monitoring your Opioid Risk Tool ORT .6 Tools for assessing function and pain .6 Assessing effects of chronic opioid Urine drug testing UDT .8 Methods of Drugs or drug classes to Interpreting Specialty Unrecognized Psychological and addiction Opioid Access to specialists and Tapering or discontinuing Recognizing and managing behavioral issues during opioid Part II Guidelines for optimizing treatment when opioid doses are greater than 120mg MED .

• Y học thường thức
• Emerging Risks
• Xenotropic Murine
• Leukemia Virus Related
• Blood Borne Pathogens
• Ultrafine and Fine Aerosol
• Safety
• One health
• Emerging infectious diseases
• Animal interface
• The human environment interface
• Zoonotic disease risks
• Henipavirus research
• Carry trade
• Emerging markets
• Currency regime
• Currency intervention
• Currency option
• Public and Pediatrics
• Paediatrics
• People and Politicians
• patient involvement
• risks and benefits
• informed decision
• Wastewater
• Maillard Reaction
• Pros and Cons
• rapidly developing
• Uniqueness of CADASIL
• Research Applications
• Procedural Techniques
• Risks and Complications
• Contrast Related Complications
• health problems
• Conceptual Model
• Carbon Dynamics
• Environmental Carcinogenesis
• Occupational Settings
• Chernobyl Accident
• Detection of Carcinogens